Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

P Denton

Showing results (441-450 of 607) with videos related to

Pageof 61
Sort By:
BMC Musculoskeletal Disorders|February 8, 2012
Pressure and pain in systemic sclerosis/scleroderma--an evaluation of a simple intervention (PISCES): randomised controlled trial protocolBegonya Alcacer-Pitarch, Maya H Buch, Janine Gray, et al.
The Journal of Biological Chemistry|March 27, 2004
Endothelin-1 induces expression of matrix-associated genes in lung fibroblasts through MEK/ERKShi-wen Xu, Sarah L Howat, Elisabetta A Renzoni, et al.
Arthritis Care & Research|August 27, 2014
Validation of a novel radiographic scoring system for calcinosis affecting the hands of patients with systemic sclerosisLorinda Chung, Antonia Valenzuela, David Fiorentino, et al.
Genome Medicine|March 24, 2017
A novel multi-network approach reveals tissue-specific cellular modulators of fibrosis in systemic sclerosisJaclyn N Taroni, Casey S Greene, Viktor Martyanov, et al.
Clinical and Experimental Rheumatology|August 17, 2024
A randomised, parallel-group, double-blind, placebo-controlled phase 3 study to Determine the effectiveness of the type I interferon receptor antibody, Anifrolumab, In SYstemic sclerosis: DAISY study design and rationaleDinesh Khanna, Christopher P Denton, Shervin Assassi, et al.
Rheumatology (Oxford, England)|December 15, 2010
Registries in systemic sclerosis: a worldwide experienceFelice Galluccio, Ulrich A Walker, Svetlana Nihtyanova, et al.
Journal of the American College of Cardiology|June 27, 2009
Updated clinical classification of pulmonary hypertensionGérald Simonneau, Ivan M Robbins, Maurice Beghetti, et al.
Annals of the Rheumatic Diseases|July 7, 2021
Molecular basis for clinical diversity between autoantibody subsets in diffuse cutaneous systemic sclerosisKristina Elizabeth Neergaard Clark, Corrado Campochiaro, Eszter Csomor, et al.
Arthritis Research & Therapy|October 28, 2019
Early treatment with ambrisentan of mildly elevated mean pulmonary arterial pressure associated with systemic sclerosis: a randomized, controlled, double-blind, parallel group study (EDITA study)Zixuan Pan, Alberto M Marra, Nicola Benjamin, et al.
Advances in Neurology|October 9, 1999
Studies of the lethargic (lh/lh) mouse model of absence seizures: regulatory mechanisms and identification of the lh geneD A Hosford, F H Lin, Y Wang, et al.
Pageof 61

Showing results (441-450 of 607) with videos related to

Sort By:
Pageof 61
BMC Musculoskeletal Disorders|February 8, 2012
Pressure and pain in systemic sclerosis/scleroderma--an evaluation of a simple intervention (PISCES): randomised controlled trial protocolBegonya Alcacer-Pitarch, Maya H Buch, Janine Gray, et al.
The Journal of Biological Chemistry|March 27, 2004
Endothelin-1 induces expression of matrix-associated genes in lung fibroblasts through MEK/ERKShi-wen Xu, Sarah L Howat, Elisabetta A Renzoni, et al.
Arthritis Care & Research|August 27, 2014
Validation of a novel radiographic scoring system for calcinosis affecting the hands of patients with systemic sclerosisLorinda Chung, Antonia Valenzuela, David Fiorentino, et al.
Genome Medicine|March 24, 2017
A novel multi-network approach reveals tissue-specific cellular modulators of fibrosis in systemic sclerosisJaclyn N Taroni, Casey S Greene, Viktor Martyanov, et al.
Clinical and Experimental Rheumatology|August 17, 2024
A randomised, parallel-group, double-blind, placebo-controlled phase 3 study to Determine the effectiveness of the type I interferon receptor antibody, Anifrolumab, In SYstemic sclerosis: DAISY study design and rationaleDinesh Khanna, Christopher P Denton, Shervin Assassi, et al.
Rheumatology (Oxford, England)|December 15, 2010
Registries in systemic sclerosis: a worldwide experienceFelice Galluccio, Ulrich A Walker, Svetlana Nihtyanova, et al.
Journal of the American College of Cardiology|June 27, 2009
Updated clinical classification of pulmonary hypertensionGérald Simonneau, Ivan M Robbins, Maurice Beghetti, et al.
Annals of the Rheumatic Diseases|July 7, 2021
Molecular basis for clinical diversity between autoantibody subsets in diffuse cutaneous systemic sclerosisKristina Elizabeth Neergaard Clark, Corrado Campochiaro, Eszter Csomor, et al.
Arthritis Research & Therapy|October 28, 2019
Early treatment with ambrisentan of mildly elevated mean pulmonary arterial pressure associated with systemic sclerosis: a randomized, controlled, double-blind, parallel group study (EDITA study)Zixuan Pan, Alberto M Marra, Nicola Benjamin, et al.
Advances in Neurology|October 9, 1999
Studies of the lethargic (lh/lh) mouse model of absence seizures: regulatory mechanisms and identification of the lh geneD A Hosford, F H Lin, Y Wang, et al.
Pageof 61